Volume 24, Number 2—February 2018
Research
Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection
Table 1
Characteristic | Men who have sex with men, n = 65 | Heterosexual men, n = 38 | Female, n = 11 |
---|---|---|---|
Median age, y (interquartile range) |
32.0 (27.4–37.3) |
27.9 (24.6–34.6) |
26.1 (22.6–28.2) |
Sample, no. | |||
Urine* | 39 | 38 | 6 |
Rectal swab | 26 | 0 | 2 |
Cervical swab |
Not applicable |
Not applicable |
3 |
Diagnosis, no.† | |||
Nongonococcal urethritis | 37 | 33 | |
Proctitis | 8 | 0 | 0 |
Pelvic inflammatory disease | 2 | ||
Other‡ |
9 |
3 |
6 |
Asymptomatic, no. | 11 | 2 | 3 |
*Includes 1 urethral swab sample.
†Clinical diagnosis when first tested for M. genitalium.
‡Comprises urethral gonorrhea (n = 3), anal discharge (n = 3), other anal symptoms (n = 3), female dysuria (n = 2), vaginal discharge (n = 2), vaginal bleeding (n = 2), not recorded (n = 3).
Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.